|
|
Gerald Salen, Scott M. Grundy
J Clin Invest. 1973;
52(11):2822
doi:10.1172/JCI107478
Abstract |
Full text
| PDF

T
he metabolism of cholesterol and its 5-dihydro derivative, cholestanol, was investigated by means of sterol balance and isotope kinetic techniques in 3 subjects with cerebrotendinous xanthomatosis (CTX) and 11 other individuals. All subjects were hospitalized on a metabolic ward and were fed diets practically free of cholesterol and cholestanol. After the intravenous administration of [1,2-3H]cholestanol, the radioactive sterol was transported and esterified in plasma lipoproteins in an identical manner to cholesterol. In these short-term experiments, the specific activity-time curves of plasma cholestanol conformed to two-pool models in both the CTX and control groups. However, cholestanol plasma concentrations, total body miscible pools, and daily synthesis rates were two to five times greater in the CTX than control individuals. The short-term specific activity decay curves of plasma [4-14C]cholesterol also conformed to two-pool models in both groups. However, in the CTX subjects the decay was more rapid, and daily cholesterol synthesis was nearly double that of the control subjects. Plasma concentrations and the sizes of the rapidly turning over pool of exchangeable cholesterol were apparently small in the CTX subjects, and these measurements did not correlate with the large cholesterol deposits found in tendon and tuberous xanthomas.Despite active cholesterol synthesis, bile acid formation was subnormal in the CTX subjects. However, bile acid sequestration was accompanied by a rise in plasma cholestanol levels and greatly augmented fecal cholestanol outputs. In contrast, the administration of clofibrate lowered plasma cholesterol levels 50% and presumably reduced synthesis in the CTX subjects. Plasma cholesterol concentrations and fecal steroid excretion did not change significantly during this therapy.These findings indicate that the excessive tissue deposits of cholesterol and cholestanol that characterize CTX were associated with hyperactive neutral sterol synthesis. The demonstration of subnormal bile acid formation suggests that defective bile acid synthesis may predispose to the neutral sterol abnormalities.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(50)
| Title and authors |
Publication |
Year |
Cerebrotendinous Xanthomatosis (CTX): An Association of Pulverulent Cataracts and Pseudo-Dominant Developmental Delay in a Family with a Splice Site Mutation inCYP27A1— A Case Report
Rabia Bourkiza, Sarah Joyce, Himanshu Patel, Michelle Chan, Esther Meyer, Eamonn R. Maher, M. Ashwin Reddy
|
Ophthalmic Genet
|
2010 |
CEREBROTENDINOUS XANTHOMATOSIS (CHOLESTANOLOSIS)
A. Schreiner, G. Hopen, S. Skrede
|
Acta Neurologica Scandinavica
|
2009 |
THE ULTRASTRUCTURE OF LENS AND IRIS IN CEREBROTENDINOUS XANTHOMATOSIS
JOHAN H. SELAND, JON E. SLAGSVOLD
|
Acta Ophthalmologica
|
2009 |
Targeting bile-acid signalling for metabolic diseases
Charles Thomas, Roberto Pellicciari, Mark Pruzanski, Johan Auwerx, Kristina Schoonjans
|
Nat Rev Drug Discov
|
2008 |
Defects in Bile Acid Biosynthesis-Diagnosis and Treatment
Kenneth D. R. Setchell, James E. Heubi
|
Journal of Pediatric Gastroenterology and Nutrition
|
2006 |
Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis
Jacob J. Clarenbach, Bernhard Lindenthal, Maria Theresa Dotti, Antonio Federico, Joanne K. Kelleher, Klaus von Bergmann
|
Metabolism
|
2005 |
Hydrophilic 7β-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis
Ashok K Batta, Gerald Salen, G.Stephen Tint
|
Metabolism
|
2004 |
Cholestanol Metabolism, Molecular Pathology, and Nutritional Implications
Yousuke Seyama
|
Journal of Medicinal Food
|
2003 |
Human CYP7A1 deficiency: progress and enigmas
Anne Beigneux, Alan F. Hofmann, Stephen G. Young
|
J. Clin. Invest.
|
2002 |
Sterol 27-hydroxylase Deficiency: A Rare Cause of Xanthomas in Normocholesterolemic Humans
Ingemar Björkhem, Eran Leitersdorf
|
Trends in Endocrinology & Metabolism
|
2000 |
|